» Articles » PMID: 24397567

Molecular Characteristics of Extended-spectrum β-lactamase-producing Escherichia Coli in Riyadh: Emergence of CTX-M-15-producing E. Coli ST131

Overview
Publisher Biomed Central
Date 2014 Jan 9
PMID 24397567
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prevalence of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) has increased recently. The aim of this study was to further characterise and to assess the occurrence of ESBL-EC in Riyadh, to use pulsed field gel electrophoresis (PFGE) typing to investigate the epidemiology of ESBL-EC and to determine the prevalence of ST131 in ESBL-EC.

Methods: A total of 152 E. coli isolates were collected at a tertiary hospital in Riyadh from September 2010 to June 2011. Genotypic and phenotypic methods were used to characterise ESBLs. PFGE was used to determine genetic relatedness. Detection of ST131 and CTX-M-like ESBLs was performed using real-time PCR.

Results: Of 152 strains, 31 were positive for ESBLs by phenotypic methods. The blaCTX-M-15 gene was highly prevalent (30/31 strains, 96.77%) among the 31 ESBL-positive E. coli strains. The blaCTX-M-27 gene was detected in one strain. Twenty (64.5%) out of 31 of ESBL-EC were ST131. PFGE revealed 29 different pulsotypes.

Conclusions: Our study documented the high prevalence of ESBLs in E. coli isolates, with CTX-M-15 as the predominant ESBL gene. ST131 clone producing CTX-M-15 has a major presence in our hospital. The high prevalence of CTX-M producers was not due to the spread of a single clone. To the best of our knowledge, this study represents the first report of CTX-M-15 and CTX-M-27 β-lactamases and the detection of the ST131 clone in Saudi E. coli isolates.

Citing Articles

An Update on Colistin in Clinical Healthcare Unit in the Kingdom of Saudi Arabia: A Narrative Review.

Faidah H Curr Pharm Des. 2024; 30(36):2829-2834.

PMID: 39108120 DOI: 10.2174/0113816128303422240723091231.


Navigating Antibacterial Frontiers: A Panoramic Exploration of Antibacterial Landscapes, Resistance Mechanisms, and Emerging Therapeutic Strategies.

Ralhan K, Iyer K, Diaz L, Bird R, Maind A, Zhou Q ACS Infect Dis. 2024; 10(5):1483-1519.

PMID: 38691668 PMC: 11091902. DOI: 10.1021/acsinfecdis.4c00115.


Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital.

Alshaikh S, El-Banna T, Sonbol F, Farghali M Ann Clin Microbiol Antimicrob. 2024; 23(1):20.

PMID: 38402146 PMC: 10894499. DOI: 10.1186/s12941-024-00679-2.


Bacterial profile and extended spectrum beta lactamase screening of urinary tract infection among asymptomatic and symptomatic pregnant women attending antenatal care in ALERT Hospital, Addis Ababa, Ethiopia.

Getie M, Gebre-Selassie S, Getu Y, Birara S, Tiruneh C, Abebaw A SAGE Open Med. 2023; 11:20503121231197587.

PMID: 37933290 PMC: 10625732. DOI: 10.1177/20503121231197587.


Urinary Tract Infections in the Kingdom of Saudi Arabia, a Review.

Sula I, Alreshidi M, Alnasr N, Hassaneen A, Saquib N Microorganisms. 2023; 11(4).

PMID: 37110375 PMC: 10145783. DOI: 10.3390/microorganisms11040952.


References
1.
Canton R, Coque T . The CTX-M beta-lactamase pandemic. Curr Opin Microbiol. 2006; 9(5):466-75. DOI: 10.1016/j.mib.2006.08.011. View

2.
Banerjee R, Johnson J . Escherichia coli ST131: variations on a theme of clonal expansion. Enferm Infecc Microbiol Clin. 2013; 31(6):355-6. PMC: 3916147. DOI: 10.1016/j.eimc.2013.01.004. View

3.
Bindayna K, Khanfar H, Senok A, Botta G . Predominance of CTX-M genotype among extended spectrum beta lactamase isolates in a tertiary hospital in Saudi Arabia. Saudi Med J. 2010; 31(8):859-63. View

4.
Markovska R, Schneider I, Ivanova D, Keuleyan E, Stoeva T, Sredkova M . High prevalence of CTX-M-15-producing O25b-ST131 Escherichia coli clone in Bulgarian hospitals. Microb Drug Resist. 2012; 18(4):390-5. DOI: 10.1089/mdr.2011.0186. View

5.
Bonnet R, Recule C, Baraduc R, Chanal C, Sirot D, De Champs C . Effect of D240G substitution in a novel ESBL CTX-M-27. J Antimicrob Chemother. 2003; 52(1):29-35. DOI: 10.1093/jac/dkg256. View